These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 17029149)

  • 61. Standard care impact on effects of highly active antiretroviral therapy adherence interventions: A meta-analysis of randomized controlled trials.
    de Bruin M; Viechtbauer W; Schaalma HP; Kok G; Abraham C; Hospers HJ
    Arch Intern Med; 2010 Feb; 170(3):240-50. PubMed ID: 20142568
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Adherence in clinical trials and in clinical practice.
    Walsh JC
    Antivir Ther; 1999; 4 Suppl 3():49-54. PubMed ID: 16021871
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Pharmacologic consideration for the use of antiretroviral agents in the elderly.
    Rhee MS; Greenblatt DJ
    J Clin Pharmacol; 2008 Oct; 48(10):1212-25. PubMed ID: 18812611
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Effects of highly active antiretroviral therapy among HIV-infected patients. Results from randomised and observational studies.
    Kirk O
    Dan Med Bull; 2004 Feb; 51(1):63-81. PubMed ID: 16009072
    [No Abstract]   [Full Text] [Related]  

  • 65. Directly administered antiretroviral therapy in the treatment of HIV infection: benefit or burden?
    Lucas GM; Flexner CW; Moore RD
    AIDS Patient Care STDS; 2002 Nov; 16(11):527-35. PubMed ID: 12513901
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Therapeutic drug monitoring and human immunodeficiency virus (HIV) antiretroviral therapy.
    Justesen US
    Basic Clin Pharmacol Toxicol; 2006 Jan; 98(1):20-31. PubMed ID: 16433887
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Assessing adherence to antiretroviral therapy in randomized HIV clinical trials: a review of currently used methods.
    Marcellin F; Spire B; Carrieri MP; Roux P
    Expert Rev Anti Infect Ther; 2013 Mar; 11(3):239-50. PubMed ID: 23458765
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [National consensus document by GESIDA/National Aids Plan on antiretroviral treatment in adults infected by the human immunodeficiency virus (January 2011 update)].
    Panel de expertos de GESIDA y Plan Nacional sobre el Sida
    Enferm Infecc Microbiol Clin; 2011 Mar; 29(3):209.e1-103. PubMed ID: 21388714
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Predictors of response to highly active antiretroviral therapy.
    Low A; Markowitz M
    AIDS Read; 2006 Aug; 16(8):425-8, 430-1, 434, 436. PubMed ID: 16933376
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [HIV infection, antiretroviral therapy, and endothelium].
    Hürlimann D; Weber R; Enseleit F; Lüscher TF
    Herz; 2005 Sep; 30(6):472-80. PubMed ID: 16170677
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Early antiretroviral therapy: the role of cohorts.
    Sabin CA
    Curr Opin HIV AIDS; 2009 May; 4(3):200-5. PubMed ID: 19532051
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Methodological issues in the use of composite endpoints in clinical trials: examples from the HIV field.
    Wittkop L; Smith C; Fox Z; Sabin C; Richert L; Aboulker JP; Phillips A; Chêne G; Babiker A; Thiébaut R;
    Clin Trials; 2010 Feb; 7(1):19-35. PubMed ID: 20156955
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Antiretroviral regimens for treatment-experienced patients with HIV-1 infection.
    Lagnese M; Daar ES
    Expert Opin Pharmacother; 2008 Apr; 9(5):687-700. PubMed ID: 18345948
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Effects of nucleoside reverse transcriptase inhibitor backbone on the efficacy of first-line boosted highly active antiretroviral therapy based on protease inhibitors: meta-regression analysis of 12 clinical trials in 5168 patients.
    Hill A; Sawyer W
    HIV Med; 2009 Oct; 10(9):527-35. PubMed ID: 19785663
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Randomized, controlled trials of directly administered antiretroviral therapy for HIV-infected patients: questions about study population and analytical approach.
    Smith-Rohrberg D; Altice FL
    Clin Infect Dis; 2006 Nov; 43(9):1221-2; author reply 1222-3. PubMed ID: 17029149
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 4.